Fear of Complications Among Patients with Type 2 Diabetes: A Latent Profile Analysis
Yuqing Liang1, Ya'ning Yang1, Xingruo Zhang1
1School of Nursing, Anhui Medical University, Hefei, Anhui Province, 230032, People's Republic of China.
Aim:
This study aimed to identify latent profiles of fear of complications among hospitalized patients with type 2 diabetes and to examine factors associated with these profiles.
Methods:
A convenience sampling method was employed to recruit patients with type 2 diabetes from a single tertiary hospital endocrine department for a cross-sectional study. Data were collected using a general information questionnaire, Chinese version of the Fear of Complications Questionnaire, Diabetes Distress Scale, and EuroQol Five-Dimension Three-Level Scale. Latent profile analysis was performed to classify fear of complications, and group differences were examined using univariate analyses. Multinomial logistic regression was performed to explore potential associations between related factors and group classification.
Results:
A total of 324 valid questionnaires were collected. Individuals with fear of complications were categorized into three potential groups: low fear-stable (30%), moderate fear-complication-focused (47%), and high fear-high-risk vulnerable (23%). Multinomial logistic regression showed that, compared with the low fear-stable group, the presence of complications (OR = 2.591, P < 0.05), insulin therapy (OR = 4.490, P < 0.01), higher diabetes distress (OR = 2.822, P < 0.01), and poorer quality of life (OR = 0.010, P < 0.05) were independently associated with membership in the high fear-high-risk vulnerable group.
Conclusion:
Fear of complications among patients with diabetes exhibits significant categorical characteristics. These profiles differ in diabetes distress and quality of life, highlighting the potential value of stratified psychosocial interventions and complication-focused educational programs. Routine screening for fear of complications using validated brief tools may help healthcare professionals identify high risk patients early and provide targeted care support, particularly for the high fear-high-risk vulnerable group. Future research should prioritize this population and develop scientifically effective and targeted intervention programs.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


